MERRIMACK PHARMACEUTICALS, INC. SCIENTIFIC ADVISORY BOARD CONSULTING AND CONFIDENTIALITY AGREEMENTConsulting and Confidentiality Agreement • March 12th, 2018 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
This Scientific Advisory Board Consulting and Confidentiality Agreement (this “Agreement”) is entered into as of the latest dated signature on the signature page hereto (the “Effective Date”) by and between Merrimack Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and George D. Demetri, M.D. (the “Consultant”).
SEVENTH AMENDMENT OF LEASELease • March 12th, 2018 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations
This Seventh Amendment of Lease (this “Seventh Amendment”) is made and entered into as of February 6, 2018 (the “Effective Date”), by and between ARE-MA REGION NO. 59, LLC, a Delaware limited liability company (“Landlord”), as successor-in-interest to DWF IV One Kendall, LLC, as successor-in-interest to RB Kendall Fee, LLC (“Original Landlord”), and MERRIMACK PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”), with reference to the following:
